Sex differences in permanent pacemaker implantation after transcatheter aortic valve replacement: a systematic review and meta-analysis

Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials

“…Although it is well-known that the risk of developing CVD is higher in women with type 2 DM than in men, GLP-1RAs remain effective in improving CV outcomes regardless of sex [ 26 ]. Regardless, women remain underrepresented in CVOTs [ [27] , [28] , [29] ] and those with T2DM present with worse metabolic control, hence the need for guidelines and policies to optimize DM therapy specific to both male and female sex [ 30 ].…”